In other studies, miR-210 has been shown to modulate mitochondrial oxygen uptake and create a pseudo-hypoxic environment[52], or to act as an oncomiR by repressing the Myc antagonist Max-binding protein[53] (MNT) and as pro-angiomir by targeting ephrin-A3[54] in other cancers. The gene discussed is MYC; the disease is cancer.